Reverse – Zion Tech Group

Pyunkang Yul [PKY] Black Tea Time Reverse Eye Patch for Anti-Aging, Deep Nourishing with Low-Molecular Collagen, Dark Circles & Fine Line Care with Kombucha, Korean Skincare (30 Pairs)

Price: ~~$19.99~~ – $17.99
(as of Jan 30,2025 14:53:47 UTC – Details)

For external use only. Avoid contact with eyes.
Product Dimensions ‏ : ‎ 3.2 x 3.2 x 1.75 inches; 5.64 ounces
Item model number ‏ : ‎ 1104379965
Manufacturer ‏ : ‎ GENIC 5, Saneopdanji-ro 5-gil, Seongdong-myeon, Nonsan-si, Chungcheongnam-do, Republic of Korea
ASIN ‏ : ‎ B09BB7ZNW6
Country of Origin ‏ : ‎ Korea, Republic of

IMPROVE SKIN ELASTICITY BY KOMBUCHA ENERGY (Fermented Black Tea) – Kombucha is fermented from 7days to 30 days or more containing rich ingredients such as Polypheno, catechin. Pyunkang Yul Black Tea Toner delivers the power of condensed fermented Black Tea to help keep the skin firm and plump
RESTORE SKIN TO ITS YOUTHFUL BEAUTY – Enriched skin-revitalizing ingredients such as Peptide and Adenosine provide healthy energy and vitality to the skin that has lost its strength. It minimizes the appearance of dehydrated fine lines therefore boosting the youtuful-look
MOISTURE ABSORBING GEL TYPE PATCH – Pearl contained water-soluble eye patch penetrates deeply into the skin and provides a strong revitalizing power. It also boasts its high-adherence so that it can deliver its nutrient-rich essence and moisturizing factors effectively
SECRET OF RADIANT SKIN – Naturally-sourced Seaberry exctracts deliver strong vitality to the deep inside of skin.
USE TIPS FOR YOUTHFUL LOOKING SKIN – Apply to various other parts of the face where the appearance of fine lines occur such as smile lines, forehead wrinkles, neck wrinkles and the general facial area

Customers say

Customers find the skin treatment mask effective in hydrating and tightening under-eye skin. They appreciate its soothing and calming properties, as well as its value for money, puffiness reduction, and appearance. However, some have mixed opinions on the slipperiness, eye patch quality, and skin irritation.

AI-generated from the text of customer reviews

Are you looking for an effective solution to combat signs of aging around your eyes? Look no further than the Pyunkang Yul Black Tea Time Reverse Eye Patch!

These eye patches are specifically designed to target dark circles, fine lines, and dryness around the delicate eye area. Infused with low-molecular collagen and kombucha, these patches deeply nourish and hydrate the skin to improve elasticity and firmness.

With 30 pairs in each pack, you can enjoy regular treatments to keep your eyes looking youthful and radiant. Say goodbye to tired, puffy eyes and hello to a more refreshed and revitalized appearance with Pyunkang Yul Black Tea Time Reverse Eye Patch!

Try them out for yourself and experience the benefits of Korean skincare at its finest. Your eyes will thank you! #PyunkangYul #KoreanSkincare #AntiAging #EyeCare
#Pyunkang #Yul #PKY #Black #Tea #Time #Reverse #Eye #Patch #AntiAging #Deep #Nourishing #LowMolecular #Collagen #Dark #Circles #Fine #Line #Care #Kombucha #Korean #Skincare #Pairs,cosrx snail mucin peptide under eye cream

January 30, 2025

Aclarion Announces Reverse Stock Split

BROOMFIELD, CO – January 24, 2025 (NEWMEDIAWIRE) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on Wednesday, January 29, 2025, it will complete a 1-for-370 reverse stock split of its common stock.

On December 31, 2024, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to affect a reverse stock split with the exact ratio to be set by its Board of Directors. The Board resolved to set the reverse stock split at the ratio of 1-for-370. The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware effective January 28, 2025, at 5:00 p.m. Eastern Time. As a result, every three hundred seventy (370) issued shares of common stock will automatically be combined into one (1) share of common stock.

The Company believes that affecting the reverse stock split will assist in its efforts to meet the Nasdaq continued listing standards and to continue to have its common stock remain listed and traded on Nasdaq. In particular, the Company expects the reverse stock split to increase the per share price and bid price of its common stock above the $1.00 required by Nasdaq’s Minimum Bid Price Rule.

Shares of the Company’s common stock will be assigned a new CUSIP number (655187300) and are expected to begin trading on a split-adjusted basis on Wednesday, January 29, 2025.

The reverse stock split will not change the authorized number of shares of the Company’s common stock. No fractional shares will be issued and any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share. Therefore, stockholders with less than 370 shares will receive one share of stock.

The reverse stock split will apply to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable will be adjusted proportionately as a result of the reverse stock split. The conversion or exercise prices of any outstanding warrants or stock options will also be proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

Once the reverse stock split becomes effective, stockholders holding shares through a brokerage account will have their shares automatically adjusted to reflect the 1-for-370 reverse stock split. Existing stockholders holding common stock certificates will receive a letter of transmittal from Aclarion’s transfer agent, Vstock Transfer, with specific instructions regarding the exchange of shares.

The Company expects to have its issued and outstanding common shares decrease from approximately 185 million pre-split shares to approximately 500,000 post-split shares outstanding as a result of the reverse stock split.

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com – Opens in new window.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com

Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com

Aclarion, a leading technology company, has announced a reverse stock split in an effort to streamline operations and improve shareholder value. The reverse stock split will combine multiple shares of the company’s common stock into a single share, effectively reducing the total number of outstanding shares.

This move comes as Aclarion looks to position itself for future growth and expansion in the competitive tech market. By reducing the number of shares outstanding, the company hopes to increase the value of its stock and attract potential investors.

Shareholders can expect to receive updated information from Aclarion regarding the reverse stock split, including the exact ratio at which shares will be combined. The company is committed to transparency throughout this process and ensuring that shareholders are informed every step of the way.

Overall, Aclarion’s reverse stock split is a strategic move aimed at strengthening the company’s financial position and driving long-term value for its investors. Stay tuned for more updates on this exciting development.

Tags:

Aclarion reverse stock split
Aclarion stock news
Aclarion company update
Aclarion reverse split details
Aclarion stock market
Aclarion financial news
Aclarion stock split announcement
Aclarion reverse split impact
Aclarion stock price update
Aclarion reverse split analysis

#Aclarion #Announces #Reverse #Stock #Split

January 30, 2025

Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split

BROOMFIELD, CO – January 28, 2025 (NEWMEDIAWIRE) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced revised timing and a revised split ratio for its pending reverse stock split of its common stock.

The Company’s revised timing is for the reverse stock split to be effective before market open on Thursday January 30, 2025. The Company’s revised ratio for the reverse stock split is 1-for-335.

On December 31, 2024, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to affect a reverse stock split with the exact ratio to be set by its Board of Directors. The Board resolved to set the reverse stock split at the ratio of 1-for-335. The Company filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware effective January 29, 2025, at 5:00 p.m. Eastern Time. As a result, every three hundred thirty five (335) issued shares of common stock will automatically be combined into one (1) share of common stock.

The Company believes that affecting the reverse stock split will assist in its efforts to meet the Nasdaq continued listing standards and to continue to have its common stock remain listed and traded on Nasdaq. In particular, the Company expects the reverse stock split to increase the per share price and bid price of its common stock above the $1.00 required by Nasdaq’s Minimum Bid Price Rule.

Shares of the Company’s common stock will be assigned a new CUSIP number (655187300) and are expected to begin trading on a split-adjusted basis on Thursday, January 30, 2025.

The reverse stock split will not change the authorized number of shares of the Company’s common stock. No fractional shares will be issued and any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share. Therefore, stockholders with less than 335 shares will receive one share of stock.

The reverse stock split will apply to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable will be adjusted proportionately as a result of the reverse stock split. The conversion or exercise prices of any outstanding warrants or stock options will also be proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

Once the reverse stock split becomes effective, stockholders holding shares through a brokerage account will have their shares automatically adjusted to reflect the 1-for-335 reverse stock split. Existing stockholders holding common stock certificates will receive a letter of transmittal from Aclarion’s transfer agent, Vstock Transfer, with specific instructions regarding the exchange of shares.

The Company expects to have its issued and outstanding common shares decrease from approximately 169.4 million pre-split shares to approximately 500,000 post-split shares outstanding as a result of the reverse stock split.

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com

Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com

Aclarion, a leading technology company, has announced a revised split ratio and timing for its upcoming reverse stock split. The company has decided to proceed with a 1-for-5 reverse stock split, which will take effect on [date]. This revised split ratio will help streamline the company’s capital structure and improve overall shareholder value.

The reverse stock split will reduce the number of outstanding shares and increase the price per share, making it more attractive to potential investors. Shareholders should note that the reverse stock split will not affect their ownership percentage in the company, as the total value of their holdings will remain the same.

Aclarion’s management believes that this revised split ratio and timing will better position the company for future growth and expansion. Shareholders are encouraged to stay informed about the reverse stock split and its implications by visiting the company’s website or contacting investor relations.

Overall, Aclarion remains committed to creating value for its shareholders and driving innovation in the technology industry. Stay tuned for more updates on the reverse stock split and other exciting developments from Aclarion.

Tags:

Aclarion reverse stock split
Aclarion stock split announcement
Aclarion revised split ratio
Aclarion reverse stock split timing
Aclarion corporate update
Aclarion stock news
Aclarion reverse stock split details
Aclarion stock market update
Aclarion financial news
Aclarion reverse split information

#Aclarion #Announces #Revised #Split #Ratio #Timing #Reverse #Stock #Split

January 30, 2025

Alcremie Reverse Holo 2024 Pokemon Stellar Crown SCR T11 #065/142

Alcremie Reverse Holo 2024 Pokemon Stellar Crown SCR T11 #065/142

Price : 1.68

Ends on : N/A

View on eBay
Are you a fan of rare Pokemon cards? Look no further than the Alcremie Reverse Holo 2024 Pokemon Stellar Crown SCR T11 #065/142! This gorgeous card features the sweet and whimsical Alcremie in stunning reverse holo foil.

With only 142 copies in existence, this card is a must-have for any serious collector. Add this rare gem to your collection and watch as it becomes the crown jewel of your Pokemon card lineup. Don’t miss out on your chance to own a piece of Pokemon history with the Alcremie Reverse Holo 2024 Pokemon Stellar Crown SCR T11 #065/142!
#Alcremie #Reverse #Holo #Pokemon #Stellar #Crown #SCR #T11,alcremie 110

January 30, 2025

Alcremie Reverse Holo English Pokemon TCG BKM119

Alcremie Reverse Holo English Pokemon TCG BKM119

Price : ~~1.75~~ – 1.50

Ends on : N/A

View on eBay
Are you a fan of collecting rare and unique Pokemon cards? If so, you won’t want to miss out on the Alcremie Reverse Holo English Pokemon TCG BKM119 card!

This stunning card features the popular Alcremie Pokemon in a gorgeous holographic design that is sure to stand out in your collection. The reverse holo pattern adds an extra touch of sparkle and shine, making this card a must-have for any collector.

Whether you’re a seasoned Pokemon TCG player or just starting out, the Alcremie Reverse Holo English Pokemon TCG BKM119 card is a valuable addition to any collection. Don’t miss your chance to add this rare and beautiful card to your lineup today!
#Alcremie #Reverse #Holo #English #Pokemon #TCG #BKM119,alcremie 110

January 30, 2025

Near Mint – 2 x Pokemon Alcremie – 065/142 – Rare – Reverse Holo Scarlet & Viole

Near Mint – 2 x Pokemon Alcremie – 065/142 – Rare – Reverse Holo Scarlet & Viole

Price : ~~1.24~~ – 0.99

Ends on : N/A

View on eBay
Are you a Pokemon card collector looking for some rare finds? Look no further! We have 2 x Pokemon Alcremie cards in near mint condition available for purchase – 065/142 – Rare – Reverse Holo Scarlet & Viole. These cards are sure to make a great addition to any collection. Don’t miss out on this opportunity to snag these rare cards before they’re gone! #PokemonCards #RareFinds #CollectorsItem #NearMint
#Mint #Pokemon #Alcremie #Rare #Reverse #Holo #Scarlet #Viole,alcremie 110

January 30, 2025

Alcremie 065/142 Sv07: Stellar Crown Reverse Holo

Alcremie 065/142 Sv07: Stellar Crown Reverse Holo

Price : 1.56

Ends on : N/A

View on eBay
Attention all Pokémon collectors! Check out this stunning Alcremie 065/142 Sv07: Stellar Crown Reverse Holo card, now available for sale. This rare and beautiful card features a holographic reverse design that truly shines like a crown in the night sky.

Add this unique and eye-catching card to your collection today and watch as it becomes the crowning jewel of your Pokémon card set. Don’t miss out on the chance to own this rare and sought-after Alcremie card – get yours now before it’s gone! #Pokemon #Alcremie #StellarCrown #ReverseHolo #Collectibles
#Alcremie #Sv07 #Stellar #Crown #Reverse #Holo,alcremie 110

January 30, 2025

How Not to Die: Discover the Foods Scientifically Proven to Prevent and Reverse Disease

Price: ~~$35.99~~ – $18.89
(as of Jan 30,2025 01:16:54 UTC – Details)

From the Publisher

Publisher ‏ : ‎ Flatiron Books; 1st edition (December 8, 2015)
Language ‏ : ‎ English
Hardcover ‏ : ‎ 576 pages
ISBN-10 ‏ : ‎ 1250066115
ISBN-13 ‏ : ‎ 978-1250066114
Item Weight ‏ : ‎ 1.75 pounds
Dimensions ‏ : ‎ 6.55 x 1.7 x 9.55 inches

Customers say

Customers find the book provides helpful, informative information about nutrition. They describe it as a compelling read that inspires them to make better food choices. The content is clear, concise, and easy to understand. Readers appreciate the plant-based diet and how it makes sense. They find the humor entertaining and enjoyable. The book promotes longevity and quality of life.

AI-generated from the text of customer reviews

In a world where chronic diseases are on the rise, it’s more important than ever to take control of our health and well-being. One of the most powerful tools we have at our disposal is the food we eat.

Research has shown that certain foods have the ability to prevent and even reverse many common diseases, such as heart disease, diabetes, and cancer. By incorporating these foods into our diets, we can significantly reduce our risk of developing these debilitating conditions and increase our overall longevity.

In this post, we’ll explore some of the top foods that have been scientifically proven to prevent and reverse disease. From leafy greens and berries to nuts and seeds, these nutrient-rich superfoods can have a profound impact on our health when consumed regularly.

So if you’re looking to live a longer, healthier life, be sure to check out our list of disease-fighting foods and start incorporating them into your diet today. Remember, the power to prevent disease and live a vibrant life is in your hands – and on your plate.
#Die #Discover #Foods #Scientifically #Proven #Prevent #Reverse #Disease,vegan

January 30, 2025

LINKUP – PCIE 5.0 Riser Cable | RTX5090 RX8900 GPUs Ready | x16 128GB/s Speed | Compatible with NZXT H1 & PCIE 4.0 / PCIE 3.0 | Single Reverse Left Angle, Black 24cm

Price: $97.96
(as of Jan 30,2025 01:04:01 UTC – Details)

Product Description

pcie5-1

pcie5-2

PCIE5-Graph

pcie5-4

pcie5-5

pcie5-6

Package Dimensions ‏ : ‎ 9.84 x 5.91 x 0.75 inches; 4.7 ounces
Item model number ‏ : ‎ AG-P5-33VL-024BK
Date First Available ‏ : ‎ June 14, 2024
Manufacturer ‏ : ‎ LINKUP Technology Inc.
ASIN ‏ : ‎ B0D74FSVWL
Country of Origin ‏ : ‎ Taiwan

Designed by LINKUP AVA Team to meet PCI-E 5.0 Specs. Lengths from 10cm to 60cm for compatibility with current and future GPUs like RTX5090(ti) and RX8900(xt). Suitable for diverse applications, including Mini ITX chassis, AI apps, servers, extreme gaming, tight space PCs, and water-cooled systems.
Replaces Gen 4 and Gen 3 riser cables, enabling vertical GPU display to showcase your hardware without sacrificing Gen 5 performance. Improves air circulation, prolongs GPU lifespan, and accommodates a wide range of GPUs. Ideal for users seeking better aesthetics and efficient cooling.
Premium wires with extreme shielding ensure high performance. Compatible with other Gen 5 devices, such as M.2 SSDs, providing versatility and expandability. Industrial configurations available for diverse applications. Customization available upon request to fit any specific application.
US-based company offering direct exchange warranty and exceptional customer support. Business Pricing available for Amazon business customers, enhancing value for businesses. Enjoy peace of mind with hassle-free warranty and prompt resolution of any concerns.
Responsive online and email customer service committed to providing excellent support. All inquiries addressed within 24 hours, ensuring a smooth and satisfying customer experience. Trust LINKUP AVA5 PCI-E Riser Cable for top-notch performance and reliable service

Customers say

Customers are satisfied with the cable’s functionality, quality, and length. They find it works well, is of good quality, and has a perfect length. Many customers find it compatible with modern graphics cards and easy to install. However, some customers feel it offers poor value for money. There are mixed opinions on fit and speed.

AI-generated from the text of customer reviews

Introducing the LINKUP PCIE 5.0 Riser Cable!

Are you ready to take your GPU setup to the next level? Our PCIE 5.0 Riser Cable is designed to provide blazing fast x16 128GB/s speed, perfect for the latest RTX5090 and RX8900 GPUs. Whether you’re a hardcore gamer or a professional video editor, this riser cable will ensure that your graphics card performs at its best.

Not only does our riser cable offer top-of-the-line performance, but it is also compatible with the NZXT H1 case and PCIE 4.0 / PCIE 3.0 motherboards. The single reverse left angle design and sleek black finish make it a stylish addition to any build.

Upgrade your rig with the LINKUP PCIE 5.0 Riser Cable and experience the ultimate in graphics card performance. Don’t settle for anything less than the best! #PCMasterRace #GamingSetup #LINKUPRiserCable
#LINKUP #PCIE #Riser #Cable #RTX5090 #RX8900 #GPUs #Ready #x16 #128GBs #Speed #Compatible #NZXT #PCIE #PCIE #Single #Reverse #Left #Angle #Black #24cm,pcie
5.0

January 30, 2025

O HUI Reverse Activator Deep Line Treatment 1ml X 60 Pcs Anti-aging, Exp 2027

O HUI Reverse Activator Deep Line Treatment 1ml X 60 Pcs Anti-aging, Exp 2027

Price : 22.40

Ends on : N/A

View on eBay
Introducing the O HUI Reverse Activator Deep Line Treatment – the ultimate solution for anti-aging! This set includes 60 1ml packets, providing you with a long-lasting supply of potent anti-aging ingredients.

With an expiration date of 2027, you can trust that this product is fresh and effective. Say goodbye to fine lines and wrinkles with this powerful formula that works to reverse the signs of aging and restore youthful radiance to your skin.

Don’t let age hold you back – unleash the power of O HUI Reverse Activator Deep Line Treatment and embrace a more youthful complexion today!
#HUI #Reverse #Activator #Deep #Line #Treatment #1ml #Pcs #Antiaging #Exp,niacinamide

January 28, 2025

Tag: Reverse

Customers say

Customers say

Customers say